Ditchcarbon
  • Contact
  1. Organizations
  2. Seqirus UK Limited
Public Profile
Real Estate Services
GB
updated 23 days ago

Seqirus UK Limited Sustainability Profile

Company website

Seqirus UK Limited, a prominent player in the biopharmaceutical industry, is headquartered in Great Britain. Established as a subsidiary of CSL Limited, Seqirus focuses on the development and distribution of innovative vaccines and immunotherapy solutions. With a strong presence in Europe and North America, the company has made significant strides since its founding in 2015, particularly in the field of influenza vaccines. Seqirus is renowned for its unique product offerings, including the adjuvanted flu vaccine, which enhances immune response, setting it apart in a competitive market. The company has achieved notable milestones, such as being one of the largest influenza vaccine manufacturers globally. With a commitment to public health and a robust pipeline of vaccine candidates, Seqirus continues to solidify its position as a leader in the vaccine industry.

DitchCarbon Score

How does Seqirus UK Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Seqirus UK Limited's score of 41 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Seqirus UK Limited's reported carbon emissions

Inherited from CSL Limited

Seqirus UK Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of CSL Limited, which cascades its climate commitments and targets down to Seqirus. While Seqirus UK Limited does not have its own documented reduction targets, it aligns with the broader sustainability initiatives of CSL Limited. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are managed at the parent company level. As a part of its corporate family, Seqirus is expected to adhere to the climate strategies and performance metrics set by CSL Limited, which may include significant reduction targets aimed at minimising carbon footprints across all scopes of emissions. However, specific details regarding these targets or achievements have not been disclosed for Seqirus UK Limited. In summary, while Seqirus UK Limited does not provide its own emissions data or reduction targets, it is integrated into the climate commitments of CSL Limited, reflecting a commitment to sustainability within the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20182019202020212022202320242025
Scope 1
250,000,000
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
58,000,000
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
-

How Carbon Intensive is Seqirus UK Limited's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Seqirus UK Limited's primary industry is Real estate services (70), which is low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Seqirus UK Limited's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Seqirus UK Limited is in GB, which has a very low grid carbon intensity relative to other regions.

Seqirus UK Limited's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Seqirus UK Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Seqirus UK Limited's Emissions with Industry Peers

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

MedImmune, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy